Right ventricular to pulmonary artery valved conduit in congenital heart disease: clinical application and emergent progress
10.3760/cma.j.cn112434-20240416-00105
- VernacularTitle:儿童先天性心脏病中右心室－肺动脉带瓣管道：临床应用与研究进展
- Author:
Xiaohui ZHONG
1
;
Zhuo SHI
;
Xiangming FAN
Author Information
1. 浙江大学医学院附属儿童医院心胸外科 国家儿童健康与疾病临床医学研究中心 国家儿童区域医疗中心，杭州 310052
- From:
Chinese Journal of Thoracic and Cardiovascular Surgery
2024;40(11):697-702
- CountryChina
- Language:Chinese
-
Abstract:
Currently, congenital heart disease is still the main cause of infant death, and surgery is the main treatment to correct congenital cardiac structural malformations. In the treatment of some complex congenital heart diseases, valved conduits are used to reconstruct the right ventricular to pulmonary artery connection and reconstruct the anatomy and hemodynamics of the normal right ventricular outflow tract. This article reviews the current usage, advantages, and disadvantages of the most commonly used right ventricular to pulmonary artery valved conduits in clinical practice: homogeneous valved conduits, heterogeneous valved conduits, and polytetrafluoroethylene valved conduits, and the right ventricular to pulmonary artery valved conduits which are emerging with the advancement of materials science and have clinical application prospects are also discussed.
